Table 2 Comparison of clinical, laboratory, CT imaging characteristics and treatment outcome between Group TB1 and Group TB2
Factor | Group TB1 | Group TB2 | χ2 | P | ||
|---|---|---|---|---|---|---|
n | % | n | % | |||
Sex | 0.081 | 0.776 | ||||
Male | 116 | 56.9 | 58 | 58.6 | ||
Female | 88 | 43.1 | 41 | 41.4 | ||
Type of case | 2.768 | 0.96 | ||||
New cases | 198 | 97.1 | 92 | 92.9 | ||
Relapse cases | 6 | 2.9 | 7 | 7.1 | ||
State of illness | 33.54 | 0 | ||||
Mild | 183 | 89.7 | 61 | 61.6 | ||
Severe | 21 | 10.3 | 38 | 38.4 | ||
Sputum smear | 8.663 | 0.003 | ||||
Negative | 134 | 65.7 | 47 | 48.0 | ||
Positive | 70 | 34.3 | 51 | 52.0 | ||
2 months smear | 5.62 | 0.018 | ||||
Negative | 188 | 96.9 | 83 | 90.2 | ||
Positive | 6 | 3.1 | 9 | 9.8 | ||
Sputum culture | 4.617 | 0.032 | ||||
Negative | 88 | 43.1 | 30 | 30.3 | ||
Positive | 116 | 56.9 | 69 | 69.7 | ||
2 months culture | 4.943 | 0.026 | ||||
Negative | 188 | 98.4 | 86 | 93.5 | ||
Positive | 3 | 1.6 | 6 | 6.5 | ||
IGRAS | 2.829 | 0.093 | ||||
Negative | 13 | 6.6 | 12 | 12.4 | ||
Positive | 185 | 93.4 | 85 | 87.6 | ||
Xpert | 6.116 | 0.013 | ||||
Negative | 99 | 48.8 | 33 | 33.7 | ||
Positive | 104 | 51.2 | 65 | 66.3 | ||
TB-DNA | 11.667 | 0.001 | ||||
Negative | 139 | 68.8 | 48 | 48.5 | ||
Positive | 63 | 31.2 | 51 | 51.5 | ||
Negative conversion rate | 8.692 | 0.003 | ||||
No | 5 | 2.5 | 10 | 10.8 | ||
Yes | 192 | 97.5 | 83 | 89.2 | ||
Cough | 8.326 | 0.004 | ||||
No | 77 | 37.7 | 21 | 21.2 | ||
Yes | 127 | 62.3 | 78 | 78.8 | ||
Expectoration | 10.197 | 0.001 | ||||
No | 112 | 54.9 | 35 | 35.4 | ||
Yes | 92 | 45.1 | 64 | 64.4 | ||
Haemoptysis | 0.813 | 0.367 | ||||
No | 186 | 91.2 | 87 | 87.9 | ||
Yes | 18 | 8.8 | 12 | 12.1 | ||
Concomitant bronchial TB | 2.351 | 0.125 | ||||
No | 128 | 62.7 | 53 | 53.5 | ||
Yes | 76 | 37.3 | 46 | 46.5 | ||
Concomitant extrapulmonary TB | 5.796 | 0.016 | ||||
No | 192 | 94.1 | 85 | 85.9 | ||
Yes | 12 | 5.9 | 14 | 14.1 | ||
Concomitant TB pleurisy | 29.907 | 0 | ||||
No | 199 | 97.5 | 78 | 78.8 | ||
Yes | 5 | 2.5 | 21 | 21.2 | ||
Lung fields | 18.435 | 0 | ||||
141 | 69.1 | 43 | 43.4 | |||
≥3 | 63 | 30.9 | 56 | 56.6 | ||
Cavity | 5.235 | 0.022 | ||||
No | 134 | 66.0 | 49 | 52.1 | ||
Yes | 69 | 34.0 | 45 | 47.9 | ||
3 months treatment outcome | 5.417 | 0.02 | ||||
Favorable | 178 | 93.7 | 81 | 85.3 | ||
Unfavorable | 12 | 6.3 | 14 | 14.7 | ||
6 months treatment outcome | 4.739 | 0.029 | ||||
Favorable | 148 | 98.0 | 69 | 92.0 | ||
Unfavorable | 3 | 2.0 | 6 | 8.0 | ||